Evidence map›Paper›PMID 25072887›Full record

ArticlePloS one2014

Timely activation of budding yeast APCCdh1 involves degradation of its inhibitor, Acm1, by an unconventional proteolytic mechanism.

Michael Melesse, Eunyoung Choi, Hana Hall, Michael J Walsh, M Ariel Geer, Mark C Hall

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael MelesseDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America.
Eunyoung ChoiDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America.
Hana HallDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America.
Michael J WalshDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America.
M Ariel GeerDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America.
Mark C HallDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America; Center for Cancer Research, Purdue University, West Lafayette, Indiana, United States of America.
Purdue University West Lafayette · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
6 · The paper itself

Abstract

Regulated proteolysis mediated by the ubiquitin proteasome system is a fundamental and essential feature of the eukaryotic cell division cycle. Most proteins with cell cycle-regulated stability are targeted for degradation by one of two related ubiquitin ligases, the Skp1-cullin-F box protein (SCF) complex or the anaphase-promoting complex (APC). Here we describe an unconventional cell cycle-regulated proteolytic mechanism that acts on the Acm1 protein, an inhibitor of the APC activator Cdh1 in budding yeast. Although Acm1 can be recognized as a substrate by the Cdc20-activated APC (APCCdc20) in anaphase, APCCdc20 is neither necessary nor sufficient for complete Acm1 degradation at the end of mitosis. An APC-independent, but 26S proteasome-dependent, mechanism is sufficient for complete Acm1 clearance from late mitotic and G1 cells. Surprisingly, this mechanism appears distinct from the canonical ubiquitin targeting pathway, exhibiting several features of ubiquitin-independent proteasomal degradation. For example, Acm1 degradation in G1 requires neither lysine residues in Acm1 nor assembly of polyubiquitin chains. Acm1 was stabilized though by conditional inactivation of the ubiquitin activating enzyme Uba1, implying some requirement for the ubiquitin pathway, either direct or indirect. We identified an amino terminal predicted disordered region in Acm1 that contributes to its proteolysis in G1. Although ubiquitin-independent proteasome substrates have been described, Acm1 appears unique in that its sensitivity to this mechanism is strictly cell cycle-regulated via cyclin-dependent kinase (Cdk) phosphorylation. As a result, Acm1 expression is limited to the cell cycle window in which Cdk is active. We provide evidence that failure to eliminate Acm1 impairs activation of APCCdh1 at mitotic exit, justifying its strict regulation by cell cycle-dependent transcription and proteolytic mechanisms. Importantly, our results reveal that strict cell-cycle expression profiles can be established independent of proteolysis mediated by the APC and SCF enzymes.

Indexed as

AnaphaseAnaphase-Promoting Complex-CyclosomeCdh1 ProteinsCell Cycle ProteinsCyclin-Dependent KinasesLeupeptinsMitosisPhosphorylationProteasome Endopeptidase ComplexProteolysisSaccharomyces cerevisiae ProteinsSaccharomycetalesSKP Cullin F-Box Protein LigasesUbiquitin-Protein LigasesAcm1 protein, S cerevisiaeAnaphase-Promoting Complex-CyclosomeATP dependent 26S proteasebenzyloxycarbonylleucyl-leucyl-leucine aldehydeCdh1 ProteinsCDH1 protein, S cerevisiaeCell Cycle ProteinsCyclin-Dependent KinasesLeupeptinsProteasome Endopeptidase ComplexSaccharomyces cerevisiae ProteinsSKP Cullin F-Box Protein LigasesUbiquitin-Protein Ligases

Identifiers

PMID25072887
PMCPMC4114781
OpenAlexW2119237156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.